Cialis
NDC 50436-4465
Product Information
Cialis is a NDA-approved product labeled by Unit Dose Services. Tadalafil is used to treat male sexual function problems (impotence or erectile dysfunction-ED). It is supplied as a yellow product. This product entry covers the primary NDC 50436-4465 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
YELLOW (C48330 - LIGHT ORANGE-YELLOW)
11 MM
12 MM
9 MM
C;5
C;10
C;20
C;2;1;2
Code Structure Chart
Product Details
What is NDC 50436-4465?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TADALAFIL (UNII: 742SXX0ICT)
- TADALAFIL (UNII: 742SXX0ICT) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- TRIACETIN (UNII: XHX3C3X673)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 402019 - tadalafil 20 MG Oral Tablet
- RxCUI: 402096 - Cialis 10 MG Oral Tablet
- RxCUI: 402096 - tadalafil 10 MG Oral Tablet [Cialis]
- RxCUI: 402097 - Cialis 20 MG Oral Tablet
- RxCUI: 402097 - tadalafil 20 MG Oral Tablet [Cialis]
* Please review the full disclaimer at the bottom of this page.